These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 2564806

  • 21. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

  • 22. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993 Apr 15; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 23. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T, Funahashi H, Satoh Y, Imai T, Takagi H.
    Jpn J Clin Oncol; 1994 Apr 15; 24(2):74-8. PubMed ID: 7908994
    [Abstract] [Full Text] [Related]

  • 24. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Feb 15; 9(2):716-21. PubMed ID: 12576440
    [Abstract] [Full Text] [Related]

  • 25. C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma.
    Heatley M, Maxwell P, Whiteside C, Toner PG.
    Pathol Res Pract; 1993 Apr 15; 189(3):261-6. PubMed ID: 7687354
    [Abstract] [Full Text] [Related]

  • 26. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Fernö M, Parwaresch R, Alm P.
    J Pathol; 1999 Jan 15; 187(2):207-16. PubMed ID: 10365096
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
    Göhring UJ, Ahr A, Scharl A, Weisner V, Neuhaus W, Crombach G, Holt JA.
    J Soc Gynecol Investig; 1995 Jan 15; 2(4):653-9. PubMed ID: 9420872
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.
    Looi LM, Cheah PL, Yap SF.
    Malays J Pathol; 1997 Jun 15; 19(1):35-9. PubMed ID: 10879240
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
    Tervahauta A, Eskelinen M, Syrjänen S, Lipponen P, Pajarinen P, Syrjänen K.
    Anticancer Res; 1991 Jun 15; 11(5):1677-81. PubMed ID: 1685075
    [Abstract] [Full Text] [Related]

  • 38. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
    Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA, Preisler HD.
    Cancer Res; 1992 May 01; 52(9):2597-602. PubMed ID: 1348967
    [Abstract] [Full Text] [Related]

  • 39. Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.
    Dykins R, Corbett IP, Henry JA, Wright C, Yuan J, Hennessy C, Lennard TJ, Angus B, Horne CH.
    J Pathol; 1991 Feb 01; 163(2):105-10. PubMed ID: 1673154
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.